Paul Tudor Jones's ANGO Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 46,314 shares of AngioDynamics, Inc. (ANGO) worth $526,590, representing 0.00% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ANGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 80,038 shares. Largest reduction occurred in Q4 2024, reducing 115,929 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +46,314 | New Buy | 46,314 | $11.37 |
| Q2 2025 | -99,876 | Sold Out | 0 | $0.00 |
| Q1 2025 | +80,038 | Add 403.46% | 99,876 | $9.39 |
| Q4 2024 | -115,929 | Reduce 85.39% | 19,838 | $9.16 |
| Q3 2024 | -3,599 | Reduce 2.58% | 135,767 | $7.78 |
| Q2 2024 | +38,163 | Add 37.71% | 139,366 | $6.05 |
| Q1 2024 | +1,823 | Add 1.83% | 101,203 | $5.87 |
| Q4 2023 | +344 | Add 0.35% | 99,380 | $7.84 |
| Q3 2023 | +51,406 | Add 107.93% | 99,036 | $7.31 |
| Q2 2023 | +23,677 | Add 98.85% | 47,630 | $10.43 |
| Q1 2023 | -32,862 | Reduce 57.84% | 23,953 | $0.01 |
| Q4 2022 | -11,626 | Reduce 16.99% | 56,815 | $0.01 |
| Q3 2022 | -11,515 | Reduce 14.40% | 68,441 | $20.46 |
| Q2 2022 | -2,313 | Reduce 2.81% | 79,956 | $19.35 |
| Q1 2022 | +60,484 | Add 277.64% | 82,269 | $21.54 |
| Q4 2021 | +14,022 | Add 180.63% | 21,785 | $27.59 |
| Q3 2021 | +7,763 | New Buy | 7,763 | $25.89 |
| Q4 2019 | -23,920 | Sold Out | 0 | $0.00 |
| Q3 2019 | -33,087 | Reduce 58.04% | 23,920 | $18.44 |
| Q2 2019 | +57,007 | New Buy | 57,007 | $19.68 |
| Q1 2018 | -30,168 | Sold Out | 0 | $0.00 |
| Q4 2017 | -9,273 | Reduce 23.51% | 30,168 | $16.64 |
| Q3 2017 | -8,129 | Reduce 17.09% | 39,441 | $17.09 |
| Q2 2017 | +19,269 | Add 68.09% | 47,570 | $16.21 |
| Q1 2017 | +3,327 | Add 13.32% | 28,301 | $17.35 |
| Q4 2016 | -30,385 | Reduce 54.89% | 24,974 | $16.86 |
| Q3 2016 | +55,359 | New Buy | 55,359 | $17.54 |
| Q1 2016 | -10,139 | Sold Out | 0 | $0.00 |
| Q4 2015 | -1,600 | Reduce 13.63% | 10,139 | $12.13 |
| Q3 2015 | +11,739 | New Buy | 11,739 | $13.20 |
| Q2 2015 | -13,133 | Sold Out | 0 | $0.00 |
| Q1 2015 | -3,896 | Reduce 22.88% | 13,133 | $17.82 |
| Q4 2014 | +3,205 | Add 23.18% | 17,029 | $19.03 |
| Q3 2014 | +13,824 | New Buy | 13,824 | $13.74 |
Paul Tudor Jones's AngioDynamics Investment FAQs
Paul Tudor Jones first purchased AngioDynamics, Inc. (ANGO) in Q3 2014, acquiring 13,824 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held AngioDynamics, Inc. (ANGO) for 34 quarters since Q3 2014.
Paul Tudor Jones's largest addition to AngioDynamics, Inc. (ANGO) was in Q1 2025, adding 99,876 shares worth $937,836.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 46,314 shares of AngioDynamics, Inc. (ANGO), valued at approximately $526,590.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in AngioDynamics, Inc. (ANGO) was 139,366 shares, as reported at the end of Q2 2024.